James Paul Scopa, Director at DICE Therapeutics, Inc. (DICE), sold 40,719 shares at $29.05 ($291K) on 2023-03-17, disclosed to the SEC on 2023-03-21.
Open-market sale of $290k DICE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 30,719 | $0 | 0.0% |
| 2 | $29.05 | 10,000 | $291K | 100.0% |
| Total | $7.13 avg | 40,719 | $291K | 100% |
| Filing → |
| DICE | BUY | 2021-09-16 | $102K | — | Filing → |
| ADVM | BUY | 2020-02-14 | $138K | — | Filing → |
| ADVM | BUY | 2019-05-06 | $134K | — | Filing → |